This article reviews the current literature on the efficacy of pharmacologic, dietary and psychosocial interventions for FAP and IBS in children and adolescents. Although most children and ...
There are several theories about the origins of IBS but it's unclear exactly why. Still, there are treatments no matter the ...
Bowel movements, bloating, and other digestive issues may not be the easiest topics to discuss with your doctor, but having a ...
("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, ...
Aim: To assess the SIBO prevalence and symptoms improvement in IBS children after treatment with Rifaximin. Study design: 43 (mean age 9,5 ys) consecutive children affected by IBS according to ...